There is an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared to those with carbapenem-susceptible Enterobacteriaceae (CSE), with significant variation in antibiotic treatment for those with CRE infections. This according to a multicenter matched cohort study that assessed the impact of isolation of CRE from a clinical culture on 30-day all-cause mortality relative to isolation of CSE. All patients aged <21 years hospitalized at 3 different hospitals between January 1, 2011, and July 1, 2016 were eligible for inclusion. Patients with index clinical cultures positive for CRE were matched in a 2:1 ratio to those with clinical cultures positive for CSE. Researchers found:
- During the 5.5-year study period, 72 patients with a clinical culture positive for CRE were identified and matched to 144 control patients with a clinical culture positive for CSE.
- Patients with CRE had a 6-fold greater risk of mortality relative to patients with CSE.
- There was significant variation in antibiotic treatment strategies among infected patients.
Chiotos K, Tamma PD, Flett KB, et al. Increased 30-day mortality associated with carbapenem-resistant Enterobacteriaceae in children. [Published online ahead of print September 10, 2018]. Open Forum Infect Dis. doi:10.1093/ofid/ofy222.
This Week's Must Reads
Disparities and Risk Factors for Septicemia Deaths , Open Forum Infect Dis; ePub 2018 Nov 15; Kempker, et al
Predicting Severe Outcomes in US Norovirus Outbreaks, J Infect Dis; ePub 2018 Nov 15; Burke, et al
RSV vs Influenza in Hospitalized Older Adults, Clin Infect Dis; ePub 2018 Nov 19; Ackerson, et al
Differences in HPV Seroprevalence By Sex, Clin Infect Dis; ePub 2018 Nov 24; Lewis, et al
Genital Wart Recurrence Among Unvaccinated Men, J Infect Dis; ePub 2018 Nov 2; Giuliano, et al
Must Reads in Antimicrobial-resistant infections
Pyrosequencing for the Clinical Management of TB, Clin Infect Dis; ePub 2018 Nov 1; Lowenthal, et al
GI Microbiota Disruption with CRPA in ICU Patients, Clin Infect Dis; ePub 2018 Nov 1; Pettigrew, et al
New IDSA Guideline for Management of OPAT, Clin Infect Dis; ePub 2018 Nov 13; Norris, et al
OPAT Outcomes in SNFs vs HHCs, Open Forum Infect Dis; ePub 2018 Oct 24; Townsend, et al
De-escalation of Antimicrobial Therapy on CDI Risk, Clin Infect Dis; ePub 2018 Oct 12; Seddon, et al